MATWIN International Board

MATWIN International Board is a strategic committee unique in Europe.

It gathers international industry leaders from the global oncology R&D department of MATWIN’s industrial partners and academic leaders in oncology coming from all over Europe. This unique Board interviews project leaders, provide recommendations, and label those with the highest industrial development transfer potential.

For 14 years, the Board members meet once a year to interview the best projects selected through the MATWIN process and consider prospects for collaboration.

Board composition

Khatereh AHMADI
Khatereh AHMADI
Industrial Board - MSD
Dr. Khatereh Ahmadi has worked in the biotech/pharma industry for 18 years. She  currently leads the Search and Evaluation Business Development team in Europe and Middle East at MSD and covers oncology BD&L in those territories. Previous to her role at...
Cedric BARRIERE
Cedric BARRIERE
Industrial Board - Sanofi
Cédric BARRIERE gained his PhD in Biology studying the regulation of the mammalian cell cycle developing and characterizing genetically engineered mouse models at the CNIO (Spanish National Cancer Center) in the lab of Pr. Mariano Barbacid. He then joined the...
James CARMICHAEL
James CARMICHAEL
Industrial Board - Bristol-Myers Squibb
Jim Carmichael is currently working at Bristol Myers Squibb, in Integrative Sciences and is based in the UK.  He was an academic Oncologist who joined industry in 2002 with AstraZeneca and subsequently joined Celgene as Chief Scientific Officer for the...
Sarah CHURCH
Sarah CHURCH
Industrial Board - Nanostring Technologies
As a Translational Research Scientist at NanoString, Sarah works on implementation and application of Immuno-oncology biomarkers using gene expression and Digital Spatial Profiling platforms. Now particularly invested in discovering immune and tumor biomarkers that can match patients with effective therapies,...
Laure DE PARSEVAL
Laure DE PARSEVAL
Industrial Board - Novartis
Laure de Parseval has more than 15 years of experience in the pharmaceutical industry, both in clinical development and research. She has held different medical positions at Novartis over the past 7 years, and most recently in Translational Clinical Oncology...
Mary FARIS
Mary FARIS
Industrial Board - Gilead
Mary FARIS est Executive Director, External Innovation, Oncology pour GILEAD
Ken HANCE
Ken HANCE
Industrial Board - GlaxoSmithKline
Ken Hance has worked in the field of Cancer Immunology for 17 years and currently serves as Vice President, Research Unit Head Tumor Cell Targeting Research Unit (TCT RU) at GlaxoSmithKline. In this role, he is responsible for new target...
Anna KRUCZYNSKI
Anna KRUCZYNSKI
Industrial Board - Pierre-Fabre
Anna KRUCZYNSKI obtained her PhD in cellular pharmacology at Paul Sabatier University Toulouse in 1991. Then she completed her training at the National Veterinary School in Toulouse and Lyon. She started her professional carreer for Pierre Fabre in 1991 with...
Valérie MÉRESSE NAEGELEN
Valérie MÉRESSE NAEGELEN
Industrial Board - Roche
Dr Valérie MÉRESSE NAEGELEN is Global Senior Oncology Clinical Leader, Oncology Insight, Pharma research and Early Development (pRED) at Hoffmann La Roche Dr Méresse Naegelen has over 20 years of experience in translational research and late and early clinical development...
Dr Mark PEARSON
Dr Mark PEARSON
Industrial Board - Boehringer-Ingelheim
  Dr. Mark Pearson received his BA from the University of Oxford and completed his doctoral studies at the University of Manchester in 1996. Subsequently, he worked on the role of the PML-RARa fusion oncogene in regulation of p53 at...
Andrew RANKIN
Andrew RANKIN
Industrial Board - Amgen
Dr. Rankin is an Executive Director in Oncology at Amgen Inc leading the Immuno-Oncology research team. In this role, he is responsible for securing strategic alignment across functions to prioritize areas of focus as well as identifying new targets and...
Anette SOMMER
Anette SOMMER
Industrial Board - Pfizer
Anette Sommer is a biochemist by training and has more than 20 years of experience in Pharma R&D. Anette is the Emerging Science & Innovation - Lead Oncology Europe at Pfizer. Prior to joining Pfizer, Anette held several positions in...
Viia VALGE-ARCHER
Viia VALGE-ARCHER
Industrial Board - AstraZeneca
Viia VALGE-ARCHER is Senior Director, External R&D Scientific and Clinical Alliances at AstraZeneca.  Her research interests are in tumour immunology, particularly identification of barriers to development of an effective anti-tumour immune response, and the discovery and development of novel therapeutic...
Arthur BERTELSEN
Arthur BERTELSEN
Academic Board
Arthur Bertelsen is Academic Review Board member for the Starr Cancer Consortium (USA). Arthur BERTELSEN worked for Bristol-Myers Squibb Research from 2010 to 202 as Vice President Research Collaborations. In this role, Art has overall responsibility for the management of...
Jean-Pierre BIZZARI
Jean-Pierre BIZZARI
Academic Board
Jean-Pierre BIZZARI, M.D., served as Executive Vice-President, Group Head, and Clinical Oncology Development (U.S., Europe, and Asia/Japan) at Celgene from 2008 to 2015. As a world-renowned oncology expert, he is a member of the Scientific Advisory Board of the French...
Olivier HERMINE
Olivier HERMINE
Academic Board
Olivier HERMINE is Professeur at Paris Descartes University (France), hospital practitioner and has the scientific degree of doctor. He is responsible of a research group studying mechanisms of hematologic malignancy or “blood cancer”. He is also the mastocytoses reference centre...
Paul MOSS
Paul MOSS
Academic Board
Paul MOSS is Director of Research and Knowledge Transfer at the University of Birmingham and Chairman of the Infection and Immunity Board at the Medical Research Council. He served previously as Chair of the Cancer Research UK Clinical and Translational...
Solange PETERS
Solange PETERS
Academic Board
Solange Peters, MD, PhD, is a full professor and chair of medical oncology, as well as the thoracic malignancies program in the Department of Oncology at the University Hospital of Lausanne in Lausanne, Switzerland. She received both her doctorate in...
Pedro ROMERO
Pedro ROMERO
Academic Board
Pedro ROMERO obtained his MD at the School of Medicine of the National University of Colombia in Bogota. Then he performed experimental work in the field of immunology of malaria and participated in the development of malaria vaccines, initially at...
Keep up to date with MATWIN's activity by subscribing to our newsletter